Clinical trial
Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) in Patients With Advanced…
NCT00080418 · INSYS Therapeutics Inc, Industry · Completed
Key facts
| NCT number | NCT00080418 |
|---|---|
| Title | Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) in Patients With Advanced Cancer |
| Official title | Phase I Study of Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) Formulation in Patients With Advanced Cancer |
| Lead sponsor | INSYS Therapeutics Inc, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Neoplasm |
| Intervention type | Drug |
| Interventions | Liposome Entrapped Paclitaxel Easy to Use |
| Enrollment | 40 |
| Start date | Jul 1, 2003 |
| Primary completion | Jul 1, 2005 |
| Completion | Jun 1, 2010 |
| First posted | Apr 2, 2004 |
| Last update posted | Jul 4, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: